All Stories

  1. Clinical Utility of Pulmonary Function Testing in Assessing Longitudinal Outcomes of Deployed Veterans with Preserved Spirometry

    Article • Annals of the American Thoracic Society, June 2025, American Thoracic Society

    Mehrdad Arjomandi

  2. Indoor Air Pollution, Computed Tomography Airway-to-Lung Ratio and Lung Function Decline: Analyses from SPIROMICS AIR

    Article • American Review of Respiratory Disease, May 2025, American Thoracic Society

    Mehrdad Arjomandi

  3. Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung Volumes

    Article • Annals of the American Thoracic Society, April 2025, American Thoracic Society

    Mehrdad Arjomandi

  4. The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study

    Article • American Review of Respiratory Disease, November 2024, American Thoracic Society

    Mehrdad Arjomandi

  5. Trends in All-cause Mortality among U.S. Veterans with Sarcoidosis, 2004–2022

    Article • CHEST Journal, November 2024, Elsevier

    Dr Seyed Mehdi Nouraie, Mehrdad Arjomandi

  6. Self-report underestimates the frequency of the acute respiratory exacerbations of COPD but is associated with BAL neutrophilia and lymphocytosis: an observational study

    Article • BMC Pulmonary Medicine, September 2024, Springer Science + Business Media

    Mehrdad Arjomandi

  7. NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoids

    Article • Scientific Reports, July 2024, Springer Science + Business Media

    Mehrdad Arjomandi

  8. Effect of twice daily inhaled albuterol on cardiopulmonary exercise outcomes, dynamic hyperinflation, and symptoms in secondhand tobacco-exposed persons with preserved spirometry and air trapping: a randomized controlled trial

    Article • BMC Pulmonary Medicine, January 2024, Springer Science + Business Media

    Mehrdad Arjomandi

  9. Response

    Article • CHEST Journal, January 2024, Elsevier

    Mehrdad Arjomandi

  10. Effect of a single one-hour teaching session about environmental pollutants and climate change on the understanding and behavioral choices of adolescents: The BREATHE pilot randomized controlled trial

    Article • PLOS One, November 2023, PLOS

    Mehrdad Arjomandi

  11. Screening for Exposure to Beryllium Among US Veterans With a Diagnosis of Sarcoidosis, 2002-2020

    Article • CHEST Journal, November 2023, Elsevier

    Mehrdad Arjomandi

  12. Late Breaking Abstract - Lung volumes differentiate emphysema- vs. airway disease-dominant pathologies with distinct clinical features in tobacco-exposed persons with preserved spirometry in SPIROMICS

    Article • September 2023, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  13. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry

    Article • JAMA, August 2023, American Medical Association (AMA)

    Mehrdad Arjomandi

  14. Lung volumes differentiate the predominance of emphysemaversusairway disease phenotype in early COPD: an observational study of the COPDGene cohort

    Article • ERJ Open Research, July 2023, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  15. Epidemiology of Sarcoidosis in U.S. Veterans from 2003 to 2019

    Article • Annals of the American Thoracic Society, June 2023, American Thoracic Society

    Mehrdad Arjomandi

  16. Self-report Underestimates COPD Exacerbation Frequency but Is Associated With BAL Neutrophilia and Lymphocytosis

    Article • May 2023, American Thoracic Society

    Mehrdad Arjomandi

  17. Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive Bronchiolitis

    Article • CHEST Journal, March 2023, Elsevier

    Mehrdad Arjomandi

  18. Changes in Lung Volumes with Spirometric Disease Progression in COPD

    Article • Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation, January 2023, COPD Foundation

    Mehrdad Arjomandi

  19. A MUC5B Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality

    Article • American Review of Respiratory Disease, November 2022, American Thoracic Society

    Mehrdad Arjomandi

  20. Effect of ozone on allergic airway inflammation

    Article • Journal of Allergy and Clinical Immunology Global, November 2022, Elsevier

    Mehrdad Arjomandi

  21. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study

    Article • American Review of Respiratory Disease, September 2022, American Thoracic Society

    Mehrdad Arjomandi

  22. NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids

    Article • August 2022, Cold Spring Harbor Laboratory Press

    Mehrdad Arjomandi

  23. Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD

    Article • CHEST Journal, May 2022, Elsevier

    Mehrdad Arjomandi

  24. Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume

    Article • BMJ Open Respiratory Research, May 2022, BMJ

    Mehrdad Arjomandi

  25. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study

    Article • May 2022, American Thoracic Society

    Mehrdad Arjomandi

  26. Laryngeal Hypersensitivity in a Veteran Cohort with Remote Exposure to Tear Gas and Pepper Spray

    Article • May 2022, American Thoracic Society

    Mehrdad Arjomandi

  27. Smaller Baseline TLC and VC Differentiate Smokers with Preserved Spirometry (GOLD-0) Who Progress to More Severe Spirometric Obstruction (GOLD-2 to GOLD-4 versus GOLD-1): An Analysis of the Department of Veterans Affairs Electronic Health Records

    Article • May 2022, American Thoracic Society

    Mehrdad Arjomandi

  28. The Epidemiology of Sarcoidosis Among U.S. Veterans, 2000-2020

    Article • May 2022, American Thoracic Society

    Mehrdad Arjomandi

  29. Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD

    Article • CHEST Journal, April 2022, Elsevier

    Mehrdad Arjomandi

  30. Effects of short-term increases in personal and ambient pollutant concentrations on pulmonary and cardiovascular function: A panel study analysis of the Multicenter Ozone Study in oldEr subjects (MOSES 2)

    Article • Environmental Research, April 2022, Elsevier

    Mehrdad Arjomandi

  31. Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: Case Validation Study From 2 Veterans Affairs Medical Centers

    Article • JMIR Formative Research, March 2022, JMIR Publications Inc.

    Mehrdad Arjomandi

  32. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study

    Article • JMIR Medical Informatics, February 2022, JMIR Publications Inc.

    Mehrdad Arjomandi

  33. Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program

    Article • Frontiers in Genetics, February 2022, Frontiers

    Mehrdad Arjomandi

  34. Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease

    Article • Annals of the American Thoracic Society, February 2022, American Thoracic Society

    Mehrdad Arjomandi

  35. Polygenic predisposition to venous thromboembolism is associated with increased COVID-19 positive testing rates

    Article • January 2022, Cold Spring Harbor Laboratory Press

    Mehrdad Arjomandi

  36. Effect of Ozone on Allergic Airway Inflammation

    Article • January 2022, Cold Spring Harbor Laboratory Press

    Mehrdad Arjomandi

  37. Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study

    Article • Journal of Medical Internet Research, January 2022, JMIR Publications Inc.

    Mehrdad Arjomandi

  38. Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort

    Article • Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation, January 2022, COPD Foundation

    Theodore Liou, Mehrdad Arjomandi

  39. Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers

    Article • Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation, January 2022, COPD Foundation

    Mehrdad Arjomandi

  40. Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument

    Article • Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation, January 2022, COPD Foundation

    Mehrdad Arjomandi

  41. Elastin degradation markers are elevated in never-smokers with past history of prolonged exposure to secondhand tobacco smoke and are inversely associated with their lung function

    Article • December 2021, Cold Spring Harbor Laboratory Press

    Mehrdad Arjomandi

  42. Defining Resilience to Smoking-related Lung Disease: A Modified Delphi Approach from SPIROMICS

    Article • Annals of the American Thoracic Society, November 2021, American Thoracic Society

    Mehrdad Arjomandi

  43. Actigraphy informs distinct patient-centered outcomes in Pre-COPD

    Article • Respiratory Medicine, October 2021, Elsevier

    Mehrdad Arjomandi

  44. A MUC5Bgene polymorphism, rs35705950-T, confers protective effects in COVID-19 infection

    Article • September 2021, Cold Spring Harbor Laboratory Press

    Mehrdad Arjomandi

  45. Altitude effect on COPD in SPIROMICS cohort

    Article • September 2021, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  46. Classification of lung function trajectories in SPIROMICS

    Article • September 2021, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  47. Posture-induced changes in vital capacity are associated with COPD outcomes independent of airflow obstruction in SPIROMICS

    Article • September 2021, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  48. Bronchodilator responsiveness over time in SPIROMICS: Clinical characteristics

    Article • September 2021, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  49. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study (Preprint)

    Article • August 2021, JMIR Publications Inc.

    Mehrdad Arjomandi

  50. Mechanism of control of the near-wall turbulence using a micro-cavity array

    Article • Physics of Fluids, July 2021, American Institute of Physics

    Shantanu Bhat, Mehrdad Arjomandi

  51. Lung immune tone via gut-lung axis: gut-derived LPS and short-chain fatty acids’ immunometabolic regulation of lung IL-1β, FFAR2, and FFAR3 expression

    Article • AJP Lung Cellular and Molecular Physiology, July 2021, American Physiological Society

    Mehrdad Arjomandi

  52. Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function

    Article • CHEST Journal, July 2021, Elsevier

    Mehrdad Arjomandi

  53. Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: Case Validation Study From 2 Veterans Affairs Medical Centers (Preprint)

    Article • June 2021, JMIR Publications Inc.

    Mehrdad Arjomandi

  54. Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume

    Article • June 2021, Cold Spring Harbor Laboratory Press

    Mehrdad Arjomandi

  55. Actigraphy Informs Distinct Patient-Centered Outcomes in Pre-COPD

    Article • May 2021, Cold Spring Harbor Laboratory Press

    Mehrdad Arjomandi

  56. Actigraphy Informs of Distinct Patient-Centered Outcome Domains in Obstructive Lung Diseases Beyond That Measured by Respiratory Questionnaires, Lung Function, or Exercise Testing

    Article • May 2021, American Thoracic Society

    Mehrdad Arjomandi

  57. Assessment of "Percent Functional Small Airways Disease" by Parametric Response Mapping as a Potential Radiographic Biomarker of Deployment-Related Constrictive Bronchiolitis

    Article • May 2021, American Thoracic Society

    Mehrdad Arjomandi

  58. COVID-19 Infection Among Airborne Hazards Open Burn Pit Registry Participants Utilizing the VA

    Article • May 2021, American Thoracic Society

    Mehrdad Arjomandi

  59. Secondhand Smoke Alters Alveolar Macrophage Gene Expression

    Article • May 2021, American Thoracic Society

    Mehrdad Arjomandi

  60. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium

    Article • Genome Medicine, April 2021, Springer Science + Business Media

    Mehrdad Arjomandi

  61. Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study (Preprint)

    Article • April 2021, JMIR Publications Inc.

    Mehrdad Arjomandi

  62. Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: A Pilot Study from Two Veterans Affairs Medical Centers

    Article • February 2021, Cold Spring Harbor Laboratory Press

    Mehrdad Arjomandi

  63. Lung Volumes Changes Across GOLD Stages of COPD

    Article • SSRN Electronic Journal, January 2021, Elsevier

    Mehrdad Arjomandi

  64. Lower PDL1, PDL2, and AXL Expression on Lung Myeloid Cells Suggests Inflammatory Bias in Smoking and Chronic Obstructive Pulmonary Disease

    Article • American Journal of Respiratory Cell and Molecular Biology, December 2020, American Thoracic Society

    Mehrdad Arjomandi

  65. Actigraphy provides additional patient-centered outcome domains beyond those measured by survey questionnaires in COPD

    Article • September 2020, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  66. Do Ambient Ozone or Other Pollutants Modify Effects of Controlled Ozone Exposure on Pulmonary Function?

    Article • Annals of the American Thoracic Society, May 2020, American Thoracic Society

    Mehrdad Arjomandi

  67. Air Trapping in Pre-COPD Contributes to Abnormal Cardiovascular Response to Exercise

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  68. Association Between SVC-FVC and Clinical, Functional, and Radiologic Features in Obstructive Lung Disease

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  69. Current Smoking Down-Regulates Specific Alveolar Macrophage Host Defense Gene Expression Pathways

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  70. Elastin Degradation Markers Are Elevated in Never-Smokers with Past History of Prolonged Exposure to Secondhand Tobacco Smoke and Are Inversely Associated with Their Lung Function

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  71. Examination of Insomnia and Other Sleep Conditions Among Deployed US Service Members

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  72. FEV1SVC Ratio Below 0.7 Is Associated with Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers with Normal Spirometry

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  73. Intermediate (CD14++ CD16+) Monocytes Correlate with Parametric Response Mapping of Functional Small Airways Disease: Spiromics Immunophenotyping Sub-Study

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  74. Lung Volumes Differences Across GOLD Stages of COPD in VA Electronic Health Records, COPDGene, and SPIROMICS

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  75. Patient-Reported Clinical Variables Associated with Significant Air Trapping in Smokers: An Analysis of the SPIROMICS Cohort

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  76. Performance of Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: A Pilot Study from Two Veterans Affairs Medical Centers

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  77. Self-Reported Sleep Apnea Among Female Us Service Members in the Airborne Hazard Open Burn Pit Registry

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  78. Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort

    Article • May 2020, American Thoracic Society

    Mehrdad Arjomandi

  79. Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD

    Article • CHEST Journal, April 2020, Elsevier

    Mehrdad Arjomandi

  80. Military Burn Pits

    Article • American Review of Respiratory Disease, April 2020, American Thoracic Society

    Mehrdad Arjomandi

  81. <p>Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum]</p>

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2020, Taylor & Francis

    Mehrdad Arjomandi

  82. Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort

    Article • JCI Insight, February 2020, American Society for Clinical Investigation

    Mehrdad Arjomandi

  83. Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease

    Article • BMJ Open Respiratory Research, February 2020, BMJ

    Mehrdad Arjomandi

  84. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers

    Article • JAMA Internal Medicine, January 2020, American Medical Association (AMA)

    Mehrdad Arjomandi

  85. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, December 2019, American Thoracic Society

    Gary Hunninghake, Mehrdad Arjomandi

  86. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2019, Taylor & Francis

    Dr igor barjaktarevic, Mehrdad Arjomandi, Cheryl Pirozzi, Professor Jeffrey Louis Curtis, Professor Eric A Hoffman, Dr Victor Kim, Richard Kanner

  87. Patterns of development of airflow limitation in smokers with preserved spirometry and air trapping phenotype in COPDGene

    Article • September 2019, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  88. Inspiratory capacity is associated with dyspnea, exercise capacity, and survival in COPD

    Article • September 2019, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  89. Lung volume comparisons between spirometry and computed tomography in SPIROMICS

    Article • September 2019, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  90. Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES)

    Article • PLOS One, September 2019, PLOS

    Mehrdad Arjomandi

  91. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS

    Article • European Respiratory Journal, August 2019, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  92. Changes in Lung Volumes Across GOLD Stages of COPD: Implications for Mechanisms of Air Trapping

    Article • May 2019, American Thoracic Society

    Mehrdad Arjomandi

  93. Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score and Palliative Care Referrals in Patients with Chronic Obstructive Pulmonary Disease

    Article • May 2019, American Thoracic Society

    Mehrdad Arjomandi

  94. Novel Multiplexed Plasma Biomarkers and Clinical Factors Augment Risk Assessment for Indeterminate Pulmonary Nodules in Former Smokers

    Article • May 2019, American Thoracic Society

    Mehrdad Arjomandi

  95. Radiographic Lung Volumes Predict Progression to COPD in Smokers with Preserved Spirometry in SPIROMICS

    Article • May 2019, American Thoracic Society

    Mehrdad Arjomandi

  96. Unsupervised Clustering Reveals Distinct Macrophage Phenotypes Associated with COPD and COPD Exacerbation

    Article • May 2019, American Thoracic Society

    Mehrdad Arjomandi

  97. Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS

    Article • Annals of the American Thoracic Society, February 2019, American Thoracic Society

    Mehrdad Arjomandi

  98. Back to the Box: Using Lung Volumes to Predict Susceptibility to Develop Chronic Obstructive Pulmonary Disease among Smokers

    Article • Annals of the American Thoracic Society, December 2018, American Thoracic Society

    Mehrdad Arjomandi

  99. Inflammatory Phenotypes Associated with Chronic Obstructive Pulmonary Disease Increase Susceptibility to Exacerbation. Lessons from Single Cell Analysis of Lung Macrophages

    Article • Annals of the American Thoracic Society, December 2018, American Thoracic Society

    Mehrdad Arjomandi

  100. Cardiovascular function and ozone exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES)

    Article • Environment International, October 2018, Elsevier

    Mehrdad Arjomandi

  101. MA23.03 Risk Assessment for Indeterminate Pulmonary Nodules Using a Novel, Plasma-Protein Based Biomarker Assay

    Article • Journal of Thoracic Oncology, October 2018, Elsevier

    Mehrdad Arjomandi

  102. E-cigarettes versus nicotine patches for perioperative smoking cessation: a pilot randomized trial

    Article • PeerJ, September 2018, PeerJ

    Mehrdad Arjomandi

  103. Late Breaking Abstract - Effect of obesity on progression of smokers without airflow obstruction to COPD

    Article • September 2018, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  104. Modeling exacerbation using ozone exposure in COPD patients: CO3PD pilot study

    Article • September 2018, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  105. Lung volume indices predict morbidity in smokers with preserved spirometry

    Article • Thorax, July 2018, BMJ

    Mehrdad Arjomandi

  106. Marijuana Use, Respiratory Symptoms, and Pulmonary Function

    Article • Annals of Internal Medicine, July 2018, American College of Physicians

    Mehrdad Arjomandi

  107. The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk

    Article • Frontiers in Medicine, June 2018, Frontiers

    Mehrdad Arjomandi

  108. Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction

    Article • BMJ Open Respiratory Research, May 2018, BMJ

    Mehrdad Arjomandi

  109. Increasing the Resolution of Chronic Obstructive Pulmonary Disease Definition. Lessons from a Cohort with Remote but Extensive Exposure to Secondhand Tobacco Smoke

    Article • Annals of the American Thoracic Society, April 2018, American Thoracic Society

    Mehrdad Arjomandi

  110. Stability of Frequency of Severe Chronic Obstructive Pulmonary Disease Exacerbations and Health Care Utilization in Clinical Populations

    Article • Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation, January 2018, COPD Foundation

    Mehrdad Arjomandi

  111. Analytical validation of a novel multi-analyte plasma test for lung nodule characterization

    Article • Biomedical Research and Reviews, January 2018, Open Access Text Pvt, Ltd.

    Mehrdad Arjomandi

  112. Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assay

    Article • Biomedical Research and Clinical Practice, January 2018, Open Access Text Pvt, Ltd.

    Mehrdad Arjomandi

  113. Respiratory Responses to Ozone Exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES)

    Article • American Review of Respiratory Disease, December 2017, American Thoracic Society

    Mehrdad Arjomandi

  114. Diagnosing Chronic Obstructive Pulmonary Disease Among Afghanistan and Iraq Veterans: Veterans Affair's Concordance With Clinical Guidelines for Spirometry Administration

    Article • Military Medicine, September 2017, Oxford University Press (OUP)

    Mehrdad Arjomandi

  115. Modeling vascular inflammation and atherogenicity after inhalation of ambient levels of ozone: exploratory lessons from transcriptomics

    Article • Inhalation Toxicology, February 2017, Taylor & Francis

    Mehrdad Arjomandi

  116. Air trapping is associated with exercise capacity in persons without overt obstructive lung disease

    Article • September 2016, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  117. Asthma-COPD Overlap Syndrome- an Underdiagnosed Phenotype in Heavy Smokers

    Article • Journal of Allergy and Clinical Immunology, February 2016, Elsevier

    Mehrdad Arjomandi

  118. Remote secondhand smoke exposure is associated with progressive airflow limitation during exercise

    Article • September 2015, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  119. Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effects

    Article • AJP Heart and Circulatory Physiology, June 2015, American Physiological Society

    Mehrdad Arjomandi

  120. Inflammatory and Repair Pathways Induced in Human Bronchoalveolar Lavage Cells with Ozone Inhalation

    Article • PLOS One, June 2015, PLOS

    Mehrdad Arjomandi

  121. Ozone inhalation leads to a dose-dependent increase of cytogenetic damage in human lymphocytes

    Article • Environmental and Molecular Mutagenesis, December 2014, Wiley

    Mehrdad Arjomandi

  122. IQGAP1-dependent scaffold suppresses RhoA and inhibits airway smooth muscle contraction

    Article • Journal of Clinical Investigation, October 2014, American Society for Clinical Investigation

    Mehrdad Arjomandi

  123. Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, July 2014, Taylor & Francis

    Mehrdad Arjomandi

  124. Mfge8 suppresses airway hyperresponsiveness in asthma by regulating smooth muscle contraction

    Article • Proceedings of the National Academy of Sciences, December 2012, Proceedings of the National Academy of Sciences

    Mehrdad Arjomandi

  125. Identification Of Biomarkers To Monitor The Activity Of STX-100, A Humanized Anti-±v²6 Antibody, In A Phase 2a Trial In Idiopathic Pulmonary Fibrosis

    Article • May 2012, American Thoracic Society

    Mehrdad Arjomandi

  126. Oxidative Injury Due to Inhalation of Ozone Causes Dose-Dependent Cytogenetic Damage in Peripheral Blood Lymphocytes

    Article • Proceedings of the American Thoracic Society, May 2012, American Thoracic Society

    Mehrdad Arjomandi

  127. Reduced Exercise Tolerance And Pulmonary Capillary Recruitment With Remote Exposure To Secondhand Tobacco Smoke

    Article • May 2012, American Thoracic Society

    Mehrdad Arjomandi

  128. Short-Term Exposure To Ozone Causes A Dose-Dependent Reduction In Heart-Rate Variability

    Article • May 2012, American Thoracic Society

    Mehrdad Arjomandi

  129. Reduced Exercise Tolerance and Pulmonary Capillary Recruitment with Remote Secondhand Smoke Exposure

    Article • PLOS One, April 2012, PLOS

    Mehrdad Arjomandi

  130. Effects of Exercise on Systemic Inflammatory, Coagulatory, and Cardiac Autonomic Parameters in an Inhalational Exposure Study

    Article • Journal of Occupational and Environmental Medicine, April 2012, Wolters Kluwer Health

    Mehrdad Arjomandi

  131. Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Related Phenotypes in a Puerto Rican Population

    Article • Pediatric Allergy Immunology and Pulmonology, December 2011, Mary Ann Liebert Inc

    Mehrdad Arjomandi

  132. Secreted Osteopontin Is Highly Polymerized in Human Airways and Fragmented in Asthmatic Airway Secretions

    Article • PLOS One, October 2011, PLOS

    Mehrdad Arjomandi

  133. PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice

    Article • Thorax, July 2011, BMJ

    Mehrdad Arjomandi

  134. HIV-1 NEF In HIV-Associated Pulmonary Hypertension: Are There Lung-Specific Nef Signature Sequences?

    Article • May 2011, American Thoracic Society

    Mehrdad Arjomandi

  135. Low Prevalence of Chronic Beryllium Disease Among Workers at a Nuclear Weapons Research and Development Facility

    Article • Journal of Occupational and Environmental Medicine, June 2010, Wolters Kluwer Health

    Mehrdad Arjomandi

  136. Effect Of Exposure To Ambient Levels Of Ozone On Systemic Inflammation And Coagulation

    Article • May 2010, American Thoracic Society

    Mehrdad Arjomandi

  137. Pulmonary Function Abnormalities in Never-Smoking Flight Attendants Exposed to Secondhand Tobacco Smoke in the Aircraft Cabin

    Article • Journal of Occupational and Environmental Medicine, June 2009, Wolters Kluwer Health

    Mehrdad Arjomandi

  138. Osteopontin Knockout Mice Show Diminished Airway Hyperreactivity Despite Increased Eosinophilic Inflammation and IgE Production in an Experimental Model of Allergic Asthma.

    Article • April 2009, American Thoracic Society

    Mehrdad Arjomandi

  139. Osteopontin Knockout Mice Show Diminished Airway Remodeling in Response to Chronic Exposure to Ozone.

    Article • April 2009, American Thoracic Society

    Mehrdad Arjomandi

  140. Osteopontin Level in Induced Sputum Is Associated with FEV1in Asthmatic Subjects.

    Article • April 2009, American Thoracic Society

    Mehrdad Arjomandi

  141. Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Decreased Lung Function.

    Article • April 2009, American Thoracic Society

    Mehrdad Arjomandi

  142. Is There an Association Between Lifetime Cumulative Exposure and Acute Pulmonary Responses to Ozone?

    Article • Journal of Occupational and Environmental Medicine, March 2008, Wolters Kluwer Health

    Mehrdad Arjomandi

  143. Effects of Chronic and Acute Ozone Exposure on Lipid Peroxidation and Antioxidant Capacity in Healthy Young Adults

    Article • Environmental Health Perspectives, December 2007, Environmental Health Perspectives

    Mehrdad Arjomandi

  144. Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes

    Article • European Respiratory Journal, October 2007, European Respiratory Society (ERS)

    Mehrdad Arjomandi

  145. Cytogenetic damage in buccal epithelia and peripheral lymphocytes of young healthy individuals exposed to ozone

    Article • Mutagenesis, March 2006, Oxford University Press (OUP)

    Mehrdad Arjomandi

  146. Effects of Nitrogen Dioxide on Allergic Airway Responses in Subjects With Asthma

    Article • Journal of Occupational and Environmental Medicine, December 2005, Wolters Kluwer Health

    Mehrdad Arjomandi

  147. Repeated Exposure to Ozone Increases Alveolar Macrophage Recruitment into Asthmatic Airways

    Article • American Review of Respiratory Disease, August 2005, American Thoracic Society

    Mehrdad Arjomandi

  148. Sputum Induction and Bronchoscopy for Assessment of Ozone-Induced Airway Inflammation in Asthma

    Article • CHEST Journal, July 2005, Elsevier

    Mehrdad Arjomandi

  149. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits

    Article • Journal of the American College of Cardiology, November 1996, Elsevier

    Mehrdad Arjomandi

  150. 765-2 Dietary L-Arginine Attenuates Macrophage Infiltration and Intimal Hyperplasia After Balloon Injury

    Article • Journal of the American College of Cardiology, February 1995, Elsevier

    Mehrdad Arjomandi

  151. Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor

    Article • The Journal of Steroid Biochemistry and Molecular Biology, January 1994, Elsevier

    Mehrdad Arjomandi